Who Exports Folic from India — 693 Suppliers Behind a $56.1M Market
India's folic export market is supplied by 693 active exporters who collectively shipped $56.1M across 5,361 shipments. UMAVIDA PHARMA PRIVATE LIMITED leads with a 6.5% market share, followed by GRACURE PHARMACEUTICALS LIMITED and STRIDES PHARMA SCIENCE LIMITED. The top 5 suppliers together control 25.7% of total export value, reflecting a moderately competitive market structure.
Top Folic Exporters from India — Ranked by Export Value
UMAVIDA PHARMA PRIVATE LIMITED is the leading folic exporter from India, holding a 6.5% share of the $56.1M market across 5,361 shipments from 693 exporters. The top 5 suppliers — UMAVIDA PHARMA PRIVATE LIMITED, GRACURE PHARMACEUTICALS LIMITED, STRIDES PHARMA SCIENCE LIMITED, CADILA PHARMACEUTICALS LIMITED, MEDICAMEN BIOTECH LIMITED — collectively control 25.7% of total export value, indicating a competitive market. Individual shares are: UMAVIDA PHARMA PRIVATE LIMITED (6.5%), GRACURE PHARMACEUTICALS LIMITED (5.3%), STRIDES PHARMA SCIENCE LIMITED (4.9%), CADILA PHARMACEUTICALS LIMITED (4.7%), MEDICAMEN BIOTECH LIMITED (4.3%).
Top Folic Exporters from India
Ranked by export value · 693 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | UMAVIDA PHARMA PRIVATE LIMITED IRON, FOLIC ACID, VITAMIN B12 & ZINC TONFERROUS SULFATE + FOLIC ACIDOTHER: FOLIC ACID (FOLIC ACID TABLETS BP | $3.6M | 1 | 6.5% |
| 2 | GRACURE PHARMACEUTICALS LIMITED FERCEFOL B/30 TABLETS | $3.0M | 3 | 5.3% |
| 3 | STRIDES PHARMA SCIENCE LIMITED VITAFER FORTE SYRUP OF IRON AND FOLIC ACFERFOLTONE | $2.8M | 1 | 4.9% |
| 4 | CADILA PHARMACEUTICALS LIMITED VITAFER FORTE SYRUP OF IRON AND FOLIC ACFERFOLTONE1924CARTON BOXES IRON 60MG AND FOLIC ACID 400 MCG TABLETS | $2.6M | 13 | 4.7% |
| 5 | MEDICAMEN BIOTECH LIMITED IRON FOLATE[FERROUS SULFATE 200MG+FOLICPHARMACEUTICAL PRODUCTS-HARMLESS MEDICINE-FOLISAPHMECONERV FORTE (QTY-32364.0 | $2.4M | 13 | 4.3% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED IRON FOLATE[FERROUS SULFATE 200MG+FOLICVITAFER FORTE SYRUP OF IRON AND FOLIC ACFERFOLTONE | $2.3M | 8 | 4.0% |
| 7 | BIOPLUS LIFE SCIENCES PRIVATE LIMITED 1924CARTON BOXES IRON 60MG AND FOLIC ACID 400 MCG TABLETSFERUP SG 4X30 CAPSULES,FERUP SG 4X30 CAPSULES 4X | $2.2M | 11 | 3.8% |
| 8 | MICRO LABS LIMITED VITAFER FORTE SYRUP OF IRON AND FOLIC ACFERFOLTONE1924CARTON BOXES IRON 60MG AND FOLIC ACID 400 MCG TABLETS | $1.6M | 12 | 2.8% |
| 9 | BHARAT SERUMS AND VACCINES LIMITED VITAFER FORTE SYRUP OF IRON AND FOLIC ACPHARMACEUTICAL PRODUCTS-HARMLESS MEDICINE-FOLISAPHFERFOLTONE | $1.3M | 11 | 2.4% |
| 10 | MACLEODS PHARMACEUTICALS LTD VITAFER FORTE SYRUP OF IRON AND FOLIC ACFERFOLTONE1015 CTN BOX IRON60MGAND FOLIC ACID 400 MCG TABLETS | $1.1M | 5 | 2.0% |
| 11 | SIDHAANT LIFE SCIENCES PRIVATE LIMITED | $1.0M | 5 | 1.9% |
| 12 | EMCURE PHARMACEUTICALS LIMITED PHARMACEUTICAL PRODUCTS-HARMLESS MEDICINE-FOLISAPH1924CARTON BOXES IRON 60MG AND FOLIC ACID 400 MCG TABLETSFERUP SG 4X30 CAPSULES, | $935.8K | 13 | 1.7% |
| 13 | WOCKHARDT LIMITED FOLIC ACID 5MG TAB FOLIC ACID 5MG TAB 28 BLI PACKFOLIC ACID 5MG TAB 28 BLI PACK -TOTAL 20FOLIC ACID 5MG TAB 28 BLI PACK -TOTAL 40 | $914.2K | 1 | 1.6% |
| 14 | CAPLIN POINT LABORATORIES LIMITED VITAFER FORTE SYRUP OF IRON AND FOLIC ACFERFOLTONE | $836.9K | 2 | 1.5% |
| 15 | UNOSOURCE PHARMA LIMITED PHARMACEUTICAL PRODUCTS-HARMLESS MEDICINE-FOLISAPHMECONERV FORTE (QTY-32364.0HEME-UP FA -PHARMA PRODUCTS-30S | $778.2K | 3 | 1.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Folic exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Cadila Pharmaceuticals Limited | Not Listed | Yes, multiple facili | No | Not verified | WHO-GMP certifications for various facilities in India. |
| Emcure Pharmaceuticals Limited | Approved | Yes, facility certif | No | 1 | FDA approval for Dolutegravir/Lamivudine; WHO-GMP certified facility. (extranet. |
| Macleods Pharmaceuticals Ltd | Not Listed | Yes, facility certif | No | Not verified | WHO-GMP certification for facility in India. (extranet.who.int) |
| Micro Labs Limited | Not Listed | Yes, facility certif | No | Not verified | WHO-GMP certification for facility in India. (extranet.who.int) |
| Strides Pharma Science Limited | Not Listed | Yes, facility certif | No | Not verified | WHO-GMP certification for facility in India. (extranet.who.int) |
| Sun Pharmaceutical Industries Limited | Not Listed | Yes, facility certif | No | Not verified | WHO-GMP certification for facility in India. (extranet.who.int) |
| Intas Pharmaceuticals Limited | Not Listed | Yes, facility certif | Yes | Not verified | EU GMP certification obtained in 2007. |
| Zydus Lifesciences Limited | Not Listed | Yes, facility certif | No | Not verified | WHO-GMP certification for facility in India. (extranet.who.int) |
TransData Nexus reviewed the regulatory standing of 8 leading Folic exporters from India. 1 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 1 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Folic sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts over 800 pharmaceutical companies, including industry leaders such as Dr. Reddy’s Laboratories, Aurobindo Pharma, and Divi’s Laboratories. The presence of Genome Valley, India's first biotech cluster, further enhances Hyderabad's capabilities in research and development, particularly in biologics and biosimilars. This robust infrastructure makes Hyderabad a critical center for API manufacturing, which is essential for the production of various pharmaceutical formulations.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production, with major companies like Zydus Cadila, Intas Pharmaceuticals, and Torrent Pharmaceuticals headquartered in this region. The state's well-developed infrastructure, including ports and transportation networks, supports efficient manufacturing and distribution processes. This concentration of resources and expertise positions Ahmedabad and Vadodara as key players in the formulation segment of the pharmaceutical industry.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a significant export gateway for India's pharmaceutical products. With 929 pharmaceutical units, Maharashtra is a major contributor to the industry. The region's proximity to major ports facilitates seamless export operations, making it a strategic location for companies aiming to access international markets. The presence of numerous pharmaceutical firms in this area underscores its importance in the global supply chain.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi and Nalagarh in Himachal Pradesh have emerged as prominent pharmaceutical manufacturing zones, largely due to favorable tax incentives and government policies. Baddi, in particular, is recognized as India's largest pharmaceutical manufacturing hub by volume, housing over 1,000 pharmaceutical units. The region's strategic location and supportive infrastructure have attracted numerous companies, contributing significantly to the country's pharmaceutical output.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the technical and regulatory compliance capabilities of suppliers, especially those in Hyderabad for APIs and Ahmedabad-Vadodara for formulations.
- Leverage Export Infrastructure: Utilize the export facilities in the Mumbai-Thane-Raigad region to streamline international distribution channels.
- Monitor Regulatory Changes: Stay informed about policy shifts, particularly in tax incentives in regions like Baddi-Nalagarh, to optimize cost structures.
By strategically sourcing from these diverse pharmaceutical clusters, companies can enhance supply chain resilience and capitalize on the specialized strengths of each region.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Folic exporters from India
Strides Pharma Science Limited — Strides Pharma Science merges subsidiary to enhance operational efficiency
In August 2023, Strides Pharma Science Limited approved the merger of its wholly owned subsidiary, Strides Alathur Private Limited, into the parent company. This strategic move aims to improve synergies and optimize administrative and operational costs. - IMPACT: The consolidation is expected to streamline operations, potentially enhancing the company's capacity to export folic products.
Impact: The consolidation is expected to streamline operations, potentially enhancing the company's capacity to export folic products.
Strides Pharma Science Limited — Strides Pharma forms OneSource to consolidate CDMO businesses
In September 2023, Strides Pharma Science Limited announced the formation of OneSource Specialty Pharma Limited by integrating its soft gelatin capsules CDMO business with Steriscience's complex injectables and Stelis' biologics CDMO businesses. This consolidation aims to create a unified CDMO platform. - IMPACT: The establishment of OneSource may lead to increased production capabilities, potentially boosting folic product exports.
Impact: The establishment of OneSource may lead to increased production capabilities, potentially boosting folic product exports.
Cadila Pharmaceuticals Limited — Cadila Pharmaceuticals inaugurates API facility in Dahej, Gujarat
In November 2023, Cadila Pharmaceuticals Limited inaugurated a new active pharmaceutical ingredient (API) manufacturing plant in Dahej, Gujarat. The facility, built with an investment of ₹200 crore, is equipped with distributed control system (DCS) automation technology. - IMPACT: The new API plant is likely to enhance production capacity, potentially increasing the export of folic products.
Impact: The new API plant is likely to enhance production capacity, potentially increasing the export of folic products.
Common Questions — Folic Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which folic supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, UMAVIDA PHARMA PRIVATE LIMITED leads with 23 recorded shipments worth $3.6M. GRACURE PHARMACEUTICALS LIMITED (236 shipments) and STRIDES PHARMA SCIENCE LIMITED (86 shipments) are also established high-volume exporters.
Q How many folic manufacturers are there in India?
India has 693 active folic exporters with a combined export market of $56.1M across 5,361 shipments to 148 countries. The top 5 suppliers hold 25.7% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for folic from India?
Average FOB unit price: $2.90 per unit, ranging from $0.00 to $570.24. Average shipment value: $10.5K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 693 verified Indian exporters of Folic ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 5,361 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 148 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5,361 Verified Shipments
693 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists